CS267192B1 - Antimycotic agent for treatment of dermatomycoses of farm animals - Google Patents
Antimycotic agent for treatment of dermatomycoses of farm animals Download PDFInfo
- Publication number
- CS267192B1 CS267192B1 CS876546A CS654687A CS267192B1 CS 267192 B1 CS267192 B1 CS 267192B1 CS 876546 A CS876546 A CS 876546A CS 654687 A CS654687 A CS 654687A CS 267192 B1 CS267192 B1 CS 267192B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- treatment
- dermatomycoses
- animals
- farm animals
- antimycotic agent
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Riešenie sa týká prostriedku pre liečenie dermatomykóz hovadzieho dobytka a koní, ktorý nemá toxické účinky ani pri častéjšom používaní. Podstatou riešenia je, že prostriedok obsahuje 2,9 až 3,1 % hmot. dehydrochloramfenikolu rozpuštěného v zmesi glycerolu a 60 % hmot. vodného etanolu v hmotnostnom pomere 0,9 až 1,1:1.The solution relates to a composition for the treatment of dermatomycoses in cattle and horses, which does not have toxic effects even with frequent use. The essence of the solution is that the composition contains 2.9 to 3.1 wt. % dehydrochloramphenicol dissolved in a mixture of glycerol and 60 wt. % aqueous ethanol in a weight ratio of 0.9 to 1.1:1.
Description
2 CS 267 192 B12 EN 267 192 B1
Vynález sa týká antimykotického prostriedku pre liečenie dermatomykóz hospodářskýchzvierat. Prostriedok sa používá pre liečbu dermatomykóz hovádzieho dobytka, spósobenýchzoofilnými druhmi.The present invention relates to an antimycotic agent for the treatment of dermatomycoses of commercial animals. The composition is used for the treatment of bovine dermatomycoses caused by zoophilic species.
Trichophyton verrucosum a T. mentagrophytes a pre liečbu dermatomykóz koní spósobenúinfekciou Tripchophyton equinum. Uvedené druhy sa v ČSSR pri infekcii zvierat najčastejšievyskytujú. V oblasti liečby dermatomykóz hovádzieho dobytka a koní sa doteraz používajú pre lokálnuliečbu hexachlorofén v 5 %-nej hmot. koncentrácii, acidi undecylici v 15 %-nej hmot. koncen-trácii, 2-aminotridecan-2-chlórhexachlórfén v 7,5 %-nej hmot. koncentrácii alebo 2-amino-tridekan-2-chlór-4-nitrofenolát v 3 %-nej hmot. koncentrácii. Uvedené přípravky vo forměspray dávajú dobré výsledky avšak ich nevýhoda je, že sa móžu aplikovat najviac na jednutřetinu těla, inak sú toxické. Po kontakte so sliznicou oka spósobujú tažké konjuktivitídy.Pri trichofytiaze koní sa s úspechom používal na liečbu natamycin. Pri tejto liečbe zvieranesmie byť vystavené slnečnému žiareniu.Trichophyton verrucosum and T. mentagrophytes and for the treatment of equine dermatomycosis caused by infection with Tripchophyton equinum. These species are the most common in the CSSR in animal infection. In the field of the treatment of dermatomycoses of bovine and equine animals, hexachlorophene in 5% w / w is still used for local treatment. concentration, acid undecylization in 15% w / w. concentration, 2-aminotridecan-2-chlorohexachlorophene in 7.5% by weight. 2-amino-tridecane-2-chloro-4-nitrophenolate in 3% by weight; concentration. Said formulations in the form of a spray give good results but their disadvantage is that they can be applied most to one-third of the body, otherwise they are toxic. After contact with the mucous membrane of the eye, they cause severe conjunctivitis. In equine trichophytiasis, natamycin has been used with success. It may be exposed to sunlight for this treatment.
Uvedené nedostatky sú odstránené antimykotickým prostriedkom podlá vynálezu, ktoréhopodstatou je, že pozostáva z 2,9 až 3,1 % hmot. dehydrochloramfenikolu rozpuštěného v zmesiglycerolu a 60 % hmot. vodného etanolu v hmotnostnom pomere 0,9 až 1,1:1. Antimykotickýprostriedok podlá vynálezu sa připraví zahriatím zmesi glycerolu, etanolu a dehydrochloram-fenikolu na 75 až 90 °C a miernym premiešaním po dobu 10 až 20 minút. Z hladiska efektivnosti sa používanie dehydrochloramfenikolu pri liečbe dermatomykózvyrovná známým prostriedkom a naviac nie je toxický a nepoškodzuje epitel rohovky očí. PříkladThese drawbacks are eliminated by the antimycotic agent of the invention, which is that it consists of 2.9 to 3.1% by weight. % dehydrochloramphenicol dissolved in a mixture of glycerol and 60 wt. aqueous ethanol in a weight ratio of 0.9 to 1.1: 1. The antimycotic composition of the invention is prepared by heating a mixture of glycerol, ethanol and dehydrochloramphenicol to 75 to 90 ° C and gently stirring for 10 to 20 minutes. In terms of efficacy, the use of dehydrochloramphenicol in the treatment of dermatomycosis is equal to the known composition and, moreover, is not toxic and does not damage the epithelium of the cornea of the eyes. Example
Prostriedok podlá vynálezu sa připravil z dehydrochloramfenikolu, čo je odpadná látkapri výrobě chloramfenikolu, 3 g dehydrochloramfenikolu sa zmiešajú s 95 g zmesi glycerolua 60 % hmot. etanolu vo vodě v hmotnostnom pomere 11a ohřeje na teplotu 80 °C.The composition according to the invention was prepared from dehydrochloramphenicol, which is a waste material for the production of chloramphenicol, 3 g of dehydrochloramphenicol are mixed with 95 g of a glycerol mixture and 60% by weight. ethanol in water in a weight ratio of 11a is heated to 80 ° C.
Prostriedok bol odskúšaný pri liečbe dermatomykóz 327 kusov hovádzieho dobytka a 12kusov koní s úplným vyliečením po dvoch aplikáciách.The composition has been tested in the treatment of dermatomycosis of 327 bovine animals and 12 horses of total cure after two applications.
Skúšky neškodnosti boli sledované len nepriamo, t. j. ošetrovatelia, ktorí sa pri plněnípracovných povinností ako je křmenie, čistenie zvierat infikovali, použili preparát k liečbes dobrým účinkom - vyliečenie primárných ložísk s dermatofytmi Trichofyton verrucosum,Trichofyt mentagrophytes a Mikrosporum verrucosum a T. gypseum.The harmlessness tests were only indirectly investigated, i.e., nurses who, in the course of their work duties, such as feeding, animal cleaning, had been treated with a good effect treatment - healing of primary foci with the dermatophytes Trichofyton verrucosum, Trichophyte mentagrophytes and Mikrosporum verrucosum and T. gypseum.
Po aplikácii preparátu in vivo dójde po jednorázovej alebo opakovanej aplikácii ,k vyliečeniu. Po vyliečení boli brané vzorky a boli sledované vlastnosti - rastová schopnost derma-tofytov na Cychloheximidovom antibiotickom agare. Výsledky kultivácie boli hodnotené za24 dní. Zo 73 vzoriek bol rast dermatofytov zistený v 3 prípadoch t. j. 4,1 %. VzhXadomna uvedené, choré zvieratá móžu zamořovat prostredie v každom případe, t, j. 100 % a liečenézvieratá v 4,1 %. U zvierat, kde bola robená vakcinácia a revakcinácia chránenost bola maxi-málně v 80 %, Zvieratá vakcinované alebo revakcinované, kde zostali nevyliečené změny po28 dňoch boli liečené. Z celkového počtu liečených zvierat po vakcinácii a revakcináciibolo 135 kusov zvierat. Z uvedeného počtu po jednorázovej aplikácii preparátu bolo vylieče-ných 108 zvierat, t. j. 80 %. U 27 kusov zvierat po druhej aplikácii liečiva len u 1 zvierataboli zistené dve miesta novej infekcie. Nové miesta v době liečenia boli v latentnom stádiuinfekcie a Trichofyton verrucosum, teda neboli liečené. Ide o lokálnu infekciu teda aj liečbu.Opakovaná liečba bola úspěšná pri 25 zvieratách, t, j. 96 %. Ospešnosť liečby v tretom rokuklesala a v štvrtom roku efektivnost liečby po jednorázovej aplikácii liečiva klesla na53 % a po dvojrázovej aplikácii na 76 %.After application of the preparation in vivo, it will be cured after a single or repeated administration. After curing, samples were taken and the properties of the growth ability of dermatophytes on Cychloheximide antibiotic agar were investigated. The culture results were evaluated for 24 days. Of the 73 samples, dermatophyte growth was found in 3 cases, i.e. 4.1%. Disclosed herein, the diseased animals may infest the environment in each case, i.e., 100% and treated in 4.1%. In animals where vaccination and revaccination were performed, the protection was maximally 80%, the animals vaccinated or revaccinated, where untreated changes remained after 28 days were treated. Of the total number of treated animals after vaccination and revaccine, 135 animals. Of this number, 108 animals, i.e. 80%, were cured after a single administration of the preparation. Two sites of new infection were detected in 27 animals after the second drug application in only 1 animal. New sites at the time of treatment were in the latent stage of infection and Trichofyton verrucosum, thus not treated. This is a local infection and therefore a treatment. Repeated treatment was successful in 25 animals, i.e. 96%. The success rate of treatment in the third year decreased and in the fourth year the efficacy of the treatment after a single drug administration decreased to 53% and after the two-stroke application to 76%.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS876546A CS267192B1 (en) | 1987-09-10 | 1987-09-10 | Antimycotic agent for treatment of dermatomycoses of farm animals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS876546A CS267192B1 (en) | 1987-09-10 | 1987-09-10 | Antimycotic agent for treatment of dermatomycoses of farm animals |
Publications (2)
Publication Number | Publication Date |
---|---|
CS654687A1 CS654687A1 (en) | 1989-06-13 |
CS267192B1 true CS267192B1 (en) | 1990-02-12 |
Family
ID=5412783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS876546A CS267192B1 (en) | 1987-09-10 | 1987-09-10 | Antimycotic agent for treatment of dermatomycoses of farm animals |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS267192B1 (en) |
-
1987
- 1987-09-10 CS CS876546A patent/CS267192B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS654687A1 (en) | 1989-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60105283T2 (en) | COMPOSITIONS CONTAINING MOLECULAR IOD | |
DE69106656T2 (en) | Tannin extract of chestnut wood, process for its production and its use. | |
US8088408B2 (en) | Method and composition for delivery of medicants to animals | |
GB2141929A (en) | Treatment of footrot | |
Charleston | Lungworm and lice of the red deer (Cervus elaphus) and the fallow deer (Dama dama)—a review | |
CN107625765B (en) | Preparation method and application of compound ketoconazole ointment | |
CS267192B1 (en) | Antimycotic agent for treatment of dermatomycoses of farm animals | |
Halpern et al. | The action of promethazine (phenergan) in protecting mice against death due to histamine | |
CN105726523B (en) | It is a kind of to be used to treat pharmaceutical composition of animal acariasis and its preparation method and application | |
DE69427653T2 (en) | COMPOUNDS FOR PREVENTING AND TREATING HELMET INFECTIONS | |
RU2715432C1 (en) | Antiparasitic agent for treatment and prevention of animals by voluntary feeding | |
DE69938168T2 (en) | Erysipelothrix rhusiopathiae antigens and vaccine compositions | |
Spradbery et al. | The efficacy of insecticides against the screw‐worm fly (Chrysomya bezziana) | |
CN111374964A (en) | Bacteriostatic agent for pets and preparation method thereof | |
RU2749356C1 (en) | Remedy for treatment of rabbits with psoroptic mange | |
Poné et al. | In vitro activity of ethanol, cold water and hot water extracts of the bark of Canthium mannii (rubiaceae) stem on ancylostoma caninum eggs | |
AU2021102382A4 (en) | Method of Controlling Parasites | |
Farnell et al. | Field studies on etiology and control of fescue toxicosis | |
Schroder | The safety of injectable rafoxanide in cattle | |
Pfister et al. | Evaluation of controlled release molluscicide formulations with improved environmental acceptance | |
McHardy et al. | Comparison of gloxazone, an effective but toxic anaplasmacide, with imidocarb dihydrochloride | |
Jones et al. | Microbiological aspects of Listeria monocytogenes with special reference to listeriosis in animals. | |
Kerlin et al. | The survival and fecundity of buffalo flies after treatment of cattle with three anthelmintics | |
Akkermans et al. | Vaccination experiments in cattle with a live and with an inactivated Aujeszky's disease virus vaccine | |
GB2401044A (en) | Composition for treatment of skin conditions, such as sweet itch in horses, comprising an alcohol, an oil and a derivative of benzene |